Epstein–Barr virus sparks brain autoimmunity in multiple sclerosis

[1]  Mark S. Anderson,et al.  Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM , 2022, Nature.

[2]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[3]  S. Hauser.  Curing Multiple Sclerosis: How to Know When We're There , 2021, Annals of neurology.

[4]  R. Estévez,et al.  Megalencephalic Leukoencephalopathy: Insights Into Pathophysiology and Perspectives for Therapy , 2021, Frontiers in Cellular Neuroscience.

[5]  M. Shlomchik,et al.  Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity. , 2020, Immunity.

[6]  T. Olsson,et al.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis , 2017, Nature Reviews Neurology.

[7]  T. Olsson,et al.  Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins , 2016, Proceedings of the National Academy of Sciences.

[8]  J. Lünemann,et al.  EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2 , 2008, The Journal of experimental medicine.

[9]  R. Hohlfeld,et al.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis , 2008, Nature Medicine.

[10]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[11]  J. Parisi,et al.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.